FDA advisers back Pfizer’s COVID-19 vaccine for young kids

Coronavirus

A healthcare worker fills a syringe with the Pfizer COVID-19 vaccine at Jackson Memorial Hospital in Miami. President Joe Biden’s most aggressive move yet to combat the COVID-19 pandemic is almost ready to see the light of day. The government is close to publishing the details of a new vaccination-or-testing rule covering more than 80 million Americans at companies with 100 or more workers. (AP Photo/Lynne Sladky, File)

WASHINGTON (AP) – U.S. health advisers have endorsed kid-size doses of Pfizer’s COVID-19 vaccine for younger children.

The vote Tuesday by the Food and Drug Administration panel moves the U.S. closer to vaccinating children ages 5 to 11.

The FDA isn’t bound by the panel’s recommendation and is expected to make its own decision within days.

If regulators agree, shots could begin as early as late next week.

Young kids would get a third of the dose given to teens and adults.

A study found kid-size vaccinations are nearly 91% effective at preventing infections that cause symptoms.

Moderna also is studying its vaccine for young children.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories